MHC II (I-A/I-E) Antikörper (Biotin)
Kurzübersicht für MHC II (I-A/I-E) Antikörper (Biotin) (ABIN7469883)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Isotyp
- IgG2b, kappa
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Kommentare
- 
                        Matching Isotype Control: Biotin Rat IgG2b, κ Isotype Control (ABIN7469857) 
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Konzentration
- 0.5 mg/mL
- 
                                            Buffer
- PBS with 0.05 % Proclin300, 1 % BSA
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C
- 
                                            Informationen zur Lagerung
- Store at 2~8°C. Do not freeze.
 
- 
                                            
- 
    - MHC II (I-A/I-E)
- 
                                            Hintergrund
- H2-Ab1/Eb1,Major histocompatibility protein class II beta chain,MHC class II H2-IA-beta-psi,I-E beta MHC class II,MHC class II,These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.
- 
                                            Gen-ID
- 14961, 14969
- 
                                            UniProt
- P14483, O78196
 Target
- 
                    
 
                                     
                                     
                                    